COCP Message Board Post 10594534 | Cocrystal Pharma Inc.
home / stock / cocp / cocp message board
(investorshangout)
Posted on: Jun/01/2022 15:31:43
Source: investorshangout
https://investorshangout.com/post/view?id=6413622
whytestocks: $COCP News Article - Cocrystal Pharma Expands Collaboration with the National Institute of Allergy a
News, Short Squeeze, Breakout and More Instantly...
-
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...
-
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human...
-
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitor Topline data expected in 2024 from Phase 2a influenza A human challen...